-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A University of Eastern Finland trial found that taking much higher-than-recommended doses of vitamin D for five years did not affect overall mortality or rates of cardiovascular disease or cancer in older men and women
In population studies, low levels of vitamin D in the body have been associated with an increased risk of many chronic diseases and premature death
In the FIND trial, 2,495 participants (men 60 years or older and women 65 or older) were randomly assigned to receive a placebo or receive 40 or 80 micrograms of vitamin D3 daily for 5 years
Most people were not deficient in vitamin D at the start of the trial
During the five-year trial period, 119 participants developed cardiovascular disease, 129 were diagnosed with cancer, and 19 died
Findings from the trial and other similar studies showed that taking higher doses of vitamin D than recommended for many years did not significantly affect the risk of cardiovascular disease and cancer if the body's vitamin D status was adequate
In addition to these key findings, the FIND trial will provide comprehensive reports on the effects of vitamin D supplementation on type 2 diabetes, fractures and falls, mood changes, infections, pain conditions and other outcomes
